atomoxetine (Strattera)

ApprovedCompleted
0 watching 0 views this week๐Ÿ”ฅ Hot
85
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
โœ“
Phase 3
5
Approved
Indication / Disease

ADHD

Conditions

ADHD

Trial Timeline

Sep 1, 2004 โ†’ Sep 1, 2007

About atomoxetine (Strattera)

atomoxetine (Strattera) is a approved stage product being developed by Eli Lilly for ADHD. The current trial status is completed. This product is registered under clinical trial identifier NCT00181948. Target conditions include ADHD.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00181948ApprovedCompleted

Competing Products

20 competing products in ADHD

See all competitors